Health Care & Life Sciences » Pharmaceuticals | Komipharm International Co. Ltd.

Komipharm International Co. Ltd. | Ownership

Companies that own Komipharm International Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
760,044
1.38%
5,519
0%
07/31/2018
BlackRock Fund Advisors
437,129
0.79%
0
0%
09/05/2018
BlackRock Advisors (UK) Ltd.
103,249
0.19%
0
0%
09/05/2018
Van Eck Associates Corp.
101,240
0.18%
-390
0.01%
09/05/2018
Dimensional Fund Advisors LP
99,897
0.18%
-8,476
0%
04/30/2018
Mirae Asset Global Investments Co., Ltd.
66,758
0.12%
16,646
0.01%
04/30/2018
Norges Bank Investment Management
66,320
0.12%
-123,564
0%
12/31/2017
Charles Schwab Investment Management, Inc.
28,993
0.05%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
21,233
0.04%
0
0%
03/31/2018
SSgA Funds Management, Inc.
14,789
0.03%
0
0%
09/06/2018

About Komipharm International Co.

View Profile
Address
17 Gyeongje-ro
Siheung GY 15094
Korea, Republic Of
Employees -
Website http://www.komipharm.com
Updated 09/14/2018
Komipharm International Co., Ltd. engages in the development and manufacturing of natural food additives, veterinary vaccines and pharmaceuticals. It operates through Animal Health and Pharmaceuticals divisions. The Animal Health division manufactures veterinary products such as vaccines, antibiotics, antibacterial, nutrition, metabolic, immune boosters, digestive enzymes, expectorant, hormone, skin disease, anesthetic, antipyretic-analgesics and organic acid for being used to livestock, aqua and pet animals.